Psychiatry · Oklahoma City, OK
NPI
1558318030
Since 2006
Specialty
Psychiatry
Code 2084P0800X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
2316 NW 23rd St
Oklahoma City, OK, 73107
Phone (405) 525-3330
Medicare paid, 2024
$54K
889 services
Medicare patients, 2024
85
Average age 58
Drug cost, 2024
$2.0M
5,033 prescriptions
Company payments, 2025
$890
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Haisam Al-Khouri was code 99214 (office e&m - established), 430 times for 53 patients. In total Haisam Al-Khouri billed 889 services in 8 codes, and Medicare paid $54K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-03-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 430 | 53 | $84.39 | $36K |
| 99213 Office E&M - Established | Office | 286 | 53 | $53.02 | $15K |
| 96127 Behavioral Health Services | Office | 83 | 13 | $2.95 | $245 |
| 99406 Behavioral Health Services | Office | 60 | 13 | $13.56 | $814 |
By year: 2022 $75K for 1,233 services; 2023 $49K for 845 services; 2024 $54K for 889 services.
Medicare prescription drug claims, 2024
In 2024, the drug Haisam Al-Khouri prescribed most often to Medicare patients was Alprazolam, with 522 prescriptions and refills. In total Haisam Al-Khouri wrote 5,033 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 522 | 522 | 62 | $2,900 |
| Quetiapine Fumarate Generic | 271 | 292 | 40 | $2,682 |
| Duloxetine Hcl Generic | 215 | 267 | 35 | $2,368 |
| Clonazepam Generic | 188 | 188 | 29 | $1,054 |
| Trazodone Hcl Generic | 181 | 222 | 25 | $1,519 |
| Fluoxetine Hcl Generic | 177 | 191 | 26 | $985 |
| Buspirone Hcl Generic | 158 | 158 | 25 | $1,780 |
| Mirtazapine Generic | 151 | 154 | 29 | $992 |
| Hydroxyzine Pamoate Generic | 134 | 139 | 28 | $3,234 |
| Gabapentin Generic | 126 | 138 | 21 | $1,723 |
| Bupropion Xl Bupropion Hcl | 121 | 149 | 19 | $1,610 |
| Austedo Deutetrabenazine | 119 | 119 | Under 11 | $1.1M |
| Lamotrigine Generic | 115 | 132 | 22 | $954 |
| Olanzapine Odt Olanzapine | 106 | 162 | 15 | $8,308 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 99 | 99 | 13 | $3,337 |
Brand drugs: - claims; generic drugs: 4,501 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Haisam Al-Khouri $890 ($890 in general payments such as food, travel and fees) from 9 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $222.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 17 | $222 |
| Abbvie Inc. ABBV | 12 | $157 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $144 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $122 |
| Vanda Pharmaceuticals Inc. VNDA | 5 | $93.39 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $90.69 |
| Bausch Health US, LLC BHC | 1 | $23.05 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $22.53 |
| Janssen Pharmaceuticals, Inc JNJ | 1 | $15.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.